On-Demand Learning

This Year

Patent

From the program: Advanced Licensing Agreements 2013

Released on: Apr. 4, 2013

Licensing transactions are more complex than ever. The constantly evolving legal, regulatory and technical landscape drives the need to stay current in all of these key areas. Whether utilized to develop technology, expand or create market opportunities, or generate returns from existing assets, managing complex licensing transactions requires a broad and varied toolkit. Additionally, whether licensing patents, copyrights, trade secrets or trademarks, ...

Recorded on: Apr. 17, 2013

JOSE A. ESTEVES: OK. We're going to go ahead and get started with the afternoon portion of the program. [SIDE CONVERSATION] JOSE A. ESTEVES: Yes. [SIDE CONVERSATION] JOSE A. ESTEVES: All right. So we've got the first of three panels of the afternoon program. And in this panel we're going to have presentations exploring new and emerging models related to patent monetization. And we have four speakers lined up for you. Our first is Cheryl Malone. ...

Recorded on: Apr. 17, 2013

Taken from the Web Program IP Monetization 2013: Maximize the Value of Your IP Assets Recorded April, 2013 in San FranciscoAlternative and Emerging Models in Patent Monetization [01:01:31] A panel of experts will examine new and emerging models being employed in IP monetization, including the IPXI patent license exchange, crowdsourcing strategies, and emerging techniques being employed to acquire, finance and sell patents and technology.The purchase ...

Recorded on: Jan. 24, 2013

Taken from the briefing America Invents Act Pro Bono Program for Inventors and Small Businesses recorded January, 2013. The America Invents Act (AIA) requires that the Director of the United States Patent and Trademark Office (USPTO) work with local intellectual property (IP) organizations across the country in establishing pro bono patent  services for inventors and small businesses. Since the passage of this bill, four pro ...

Recorded on: Apr. 3, 2013

ROBERT GREENE STERNE: Well, welcome again, and now we're going to be addressing the very important subject of appeals from the Board to the Federal Circuit, something that I think a lot of us are woefully deficient in our appreciation of the task at hand, and we need to get up to speed on this very important piece of the puzzle. So as we start this panel discussion, first of all, let me introduce John Dragseth, who is our other faculty member, in ...

From the program: USPTO Post-Grant Patent Trials 2013

Released on: Apr. 10, 2013

Post-grant patent proceedings were pursued in record number at the USPTO in 2012. The substantial costs and uncertainty of patent litigation require the development of alternative case management strategies, which at least require consideration of challenging patents at the USPTO. To this end, patent reexamination remains a viable alternative to costly litigation or parallel path to enhance litigation positions. Yet due to the public outcry for even ...

Recorded on: Apr. 2, 2013

DANIEL L. REISNER: It's my pleasure to introduce the speakers for our last topic today. Grace Pan is a partner at Kay Scholer in our New York office. She is a graduate of Northwestern University School of Law, where she graduated Phi Delta Phi and Iota Sigma Phi. Grace speaks Chinese and Japanese, travels often to Asia, and represents numerous Asian clients with intellectual property and commercial issues. Grace is a member of numerous professional ...

From the program: Developments in Pharmaceutical and Biotech Patent Law 2013

Released on: Apr. 15, 2013

Pharmaceutical and biotech patent law is an important and rapidly changing practice area, and the program is designed to give you the information you need to maintain your practice edge, concentrating on new developments from 2012 and placing them in the context of constantly evolving areas of the law.Technological innovation, Federal Circuit appellate oversight, and Supreme Court decisions continue to drive significant changes in the law. Several ...

From the program: Patent Law Institute (7th Annual)

Released on: Apr. 2, 2013

The Institute is designed to be of ultimate practice value to all three subgroups in the patent law community: patent prosecutors, patent litigators, and strategic/transactional lawyers.Do not miss this unique opportunity to sharpen your practice skills and network with federal judges, USPTO officials, in-house counsel and outside patent lawyers.Lecture Topics  [Total time 12:46:15] Segments with an asterisk (*) are available only with the purchase ...

Recorded on: Mar. 19, 2013

DOUGLAS R. NEMEC: So we'll moving into developments in pharmaceutical and biotech patent litigation, a topic that's of interest, I think, to a narrower group of the audience than perhaps some that we've been covering. But to those of us who practice in that area, it's an area of great interest and one where there's really a lot going on in recent months and recent years. I'm happy to turn the program over to Asim Bhansali, who's a partner at Keker ...

Recorded on: Mar. 20, 2013

SCOTT ATLER: All right. We're gonna go right into the next session which is gonna be hot topics in technology transfer. We have a couple of great speakers to talk to us about this topic today. The first is Cheryl-- CHERYL FRAGIADAKIS: Thank you. SCOTT ATLER: --Fragiadakis who is head of technology transfer and intellectual property management at the Lawrence Berkeley National Laboratory. That lab is the oldest US national laboratory operated for ...

Recorded on: Apr. 2, 2013

DANIEL L. REISNER: Morning, everyone. I'm going to start with the first topic of the day, which is claim construction. Judge Holderman, about five years ago, wrote, something has to change when your boss, upon reviewing your work, continues to tell you, year after year, that you are doing your job incorrectly about 1/3 to 1/2 of the time, and your customers continue to tell you their costs are too high. Judge Holderman was speaking about the Federal ...

Recorded on: Mar. 20, 2013

SCOTT ALTER: So to keep things on time, we're gonna go ahead and get started. This is the corporate counsel panel also known as what keeps corporate in-house counsel up at night. And for that we have some outstanding corporate counsel to talk about these issues with us. Too close. Stay a little bit away from the microphone, I'm told here. Our first panelist is T. J. Angioletti who is Associate General Counsel, Technology Transactions for Netflix. ...

Recorded on: Apr. 3, 2013

SCOTT: Welcome back, everybody. We're going to get started so we can get everybody to lunch on time. So the next module is focusing on discovery, which is a new component of these PTAB mechanisms. There was, as we all learned recently thanks to the federal circuit case last week, there's certainly no discovery in inter partes reexamination. And that was pointed out by Congress, that patent owners, in particular, wanted to challenge some of these declarations ...

Released on: May. 9, 2013

Taken from the briefing Europe's New Unitary Patent Regime: One Patent, One Court recorded April, 2013.Now that 24 EU member states have signed an international treaty establishing a European unified patent court, Europe’s dream of a unified patent system is moving closer to reality. If enough participating states ratify the agreement, the EU will get a new Unitary Patent right - taking effect via a single application throughout most of the EU - and ...

Recorded on: Apr. 10, 2013

Taken from the briefing Foreign Filing Best Practices: An Update on the Patent Cooperation Treaty recorded April, 2013.With today’s global industries and markets, foreign patent protection is an essential part of IP strategy. Since entering force in 1978, the Patent Cooperation Treaty (PCT) has been a popular route for applicants acquiring patent rights in different countries because of the distinct advantages that the PCT offers versus ...

Recorded on: Apr. 2, 2013

DAVID BARR: Everyone just a brief change in our schedule. We're going to be going forward with the in-house panel on pharma and biotech litigation for the 3:00 slot. And the panel on biotech and pharma licensing in Asia will take place at 4:00. So same subject matter, just flipping those two panels. So we're pleased and privileged to have today with us three in-house counsel to discuss a lot of the issues-- maybe in more depth than we were discussing ...

From the program: Information Technology Law Institute 2013: Privacy and Cybersecurity, Mobile Advertising, Digital Distribution, Social Media and the Third Industrial Revolution

Recorded on: May. 17, 2013

Taken from the Web Program Information Technology Law Institute 2013: Privacy and Cybersecurity, Mobile Advertising, Digital Distribution, Social Media and the Third Industrial Revolution recorded May, 2013 in San Francisco.Lecture Topics  [00:58:51]How Technology Is Creating the Third Industrial Revolution and Techniques to Finance New Businesses  [00:58:51] The transformative potential of goods created with 3D printers Using technology ...

From the program: IP Enforcement and Litigation 2013: Criminal and Civil Update

Recorded on: Feb. 12, 2013

Taken from the Web Program IP Enforcement and Litigation 2013: Criminal and Civil Update recorded February, 2013 in New York. Lecture Topics  [01:02:00] Patent Enforcement Update  [01:02:00] The impact of new patent legislation on patent litigation Patent case law trends When and how to use ITC proceedings for patent or other IP enforcement Update on Proposed Amendments to ITC Rules of Practice and Procedure The ...

From the program: IP Issues in Business Transactions 2013

Released on: Mar. 12, 2013

This comprehensive program will provide an in-depth understanding of intellectual property issues that arise in corporate transactions, including the strategic role of intellectual property in a company and the many unique considerations that come into play. Learn how to assess intellectual property as a strategic asset and how to evaluate opportunities to monetize IP while avoiding costly missteps. Other essential topics addressed include IP portfolio ...

Recorded on: Mar. 20, 2013

DOUGLAS NEMEC: Welcome back, everybody. We'll get started with the first plenary session of the day. We're going to spend the next hour talking about litigation involving non-practicing entities, or patent-assertion entities, or patent trolls-- whatever term you prefer. When I started practicing-- it really wasn't all that long ago, in the 1990s-- these terms really didn't exist. Patent troll was a really unattractive patent lawyer, and a non-practicing ...

Recorded on: Apr. 2, 2013

DANIEL REISNER: I'd like to introduce our next speaker, Steve Elliott. He has an undergraduate degree in chemical engineering from MIT. He was then a process and materials engineer for Intel Corporation, where he developed integrated circuit manufacturing technology. Now Steve is a special counsel at Sullivan & Cromwell, where he represents clients in a wide range of technologies, including pharmaceuticals, medical devices, biotechnology, and ...

Released on: May. 10, 2013

Please note: CLE is not available this program.Taken from the briefing Maximizing Your IP Job Search with Loyola Chicago's PLIP 2013 recorded April, 2013.Lecture Topics  [Total Time: 00:57:58]

From the program: Open Source and Free Software 2012: Benefits, Risks and Challenges

Released on: Jan. 2, 2013

Audio CD's from the program Open Source and Free Software 2012: Benefits, Risks and Challenges, held December, 2012.

Recorded on: Apr. 17, 2013

JOSE A. ESTEVES: So to keep things moving, while our panelists take their place, I'm going to start with the introductions for our last panel. And our last panel is going to try to take things up a little bit higher, and talk about themes and issues affecting patent monetization. Our speakers, in alphabetical order, are Robert Aronoff. Robert is a Managing Partner at Pluritas, LLC. He is also the founder of Pluritas, which is a leading Intellectual ...